The global remote patient monitoring market, valued at US$24.39 billion in 2023, is forecasted to grow at a robust CAGR of 12.7%, reaching US$27.72 ...

Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Year-end Report January-December 2024. The full report is available on the Company's website. "Stronger ...

As COVID-19 surged across the US starting in 2020, so too did the use of repurposed medications such as hydroxychloroquine and ivermectin to treat COVID-19 infections. Use of these medications ...

Carnegie Mellon University has agreed to pay $4.8 million to settle a class action lawsuit filed by students who had their in-person classes moved online due to the COVID-19 pandemic in 2020.

The Company is withdrawing current submission based on FDA feedback related to shelf-life stability of a test component ...

The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

A group of Berlin researchers in collaboration with international scientists have found differences in heart inflammation caused by COVID-19, anti-COVID-19 vaccination, and non-COVID-19 myocarditis.

The affected products were described in the FDA update as packaged in a half gallon carton (64-ounce) and in cases of six units. The shelf-life of the product was detailed as 18 months if frozen ...

Detailed price information for Revive Therapeutics Ltd (RVVTF) from The Globe and Mail including charting and trades.

CLEVELAND, Ohio – After falling for three weeks in a row, the number of new COVID-19 cases in Ohio moved upward, increasing from 4,474 last week to 5,374 this week, the state reported Thursday.

The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines that target the Omicron KP.2 strain of SARS-CoV-2 which was dominant in the US in recent ...